Overview
Andrew T. Lenis, MD MS, is an Assistant Professor of Urology at CUIMC. He specializes in treating patients with bladder, kidney, prostate, testis, and penile cancers. Dr. Lenis graduated from Case Western Reserve University School of Medicine in Cleveland, Ohio, with a dual MD MS degree and Honors Distinction in Research. He then completed his surgical internship and urology residency at UCLA in Los Angeles, California. After residency, Dr. Lenis completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York City.Dr. Lenis joined CUIMC as a surgeon-scientist with an interest and specialization in urothelial cancer (tumors of the bladder, ureter, and renal pelvis). In the laboratory, Dr. Lenis works and collaborates with Michael Shen, Ph.D., who is an expert in bladder and prostate developmental and molecular biology and a pioneer in bladder tumor organoids. The American Urological Association, the American Cancer Society, and the American Society for Clinical Oncology have funded Dr. Lenis’ research. His work on urologic malignancies has been published in JAMA, the Journal of Urology, European Urology, the Journal of Clinical Oncology Precision Oncology, and Urologic Oncology. When not seeing patients or in the laboratory, Dr. Lenis enjoys spending time with his wife and two sons. They enjoy the outdoors and traveling.
Dr. Lenis is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy.
He is actively involved in clinical research, co-authoring 83 peer reviewed articles. Dr. Lenis is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Additional Areas of Focus
Dr. Lenis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.
Mount Sinai Queens Infusion Center
John Sfakianos is a Urologist practicing medicine in Astoria, New York. Dr. Sfakianos is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.
The Ruttenberg Treatment Center
John Mascarenhas is an Oncologist practicing medicine in New York, New York. Dr. Mascarenhas is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Splenectomy. Dr. Mascarenhas is currently accepting new patients.
Frequently Asked Questions about Dr. Andrew T. Lenis
How do I make an appointment with Dr. Andrew T. Lenis?
You can book an appointment with Dr. Andrew T. Lenis by calling their office at 212-305-0114. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Andrew T. Lenis a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew T. Lenis is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Andrew T. Lenis specialize in?
While Dr. Andrew T. Lenis is a Urology, they have specific expertise in Bladder Cancer, Urothelial Cancer, and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Andrew T. Lenis participate in research or clinical trials?
Yes. Dr. Andrew T. Lenis has published 83 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Andrew T. Lenis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Andrew T. Lenis accept my insurance?
Dr. Andrew T. Lenis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-0114 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Lenis isDistinguished. Learn about Bladder Cancer.
- CystectomyDr. Lenis isDistinguished. Learn about Cystectomy.
- Urothelial CancerDr. Lenis isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Muscle Invasive Bladder CancerDr. Lenis isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Lenis isAdvanced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder Cancer
- Renal Cell Carcinoma (RCC)Dr. Lenis isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- Bilateral HydronephrosisDr. Lenis isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder ReconstructionDr. Lenis isExperienced. Learn about Bladder Reconstruction.
- Chromophobe Renal Cell CarcinomaDr. Lenis isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Lenis isExperienced. Learn about Clear Cell Sarcoma.
- EndoscopyDr. Lenis isExperienced. Learn about Endoscopy.
- Familial Prostate CancerDr. Lenis isExperienced. Learn about Familial Prostate Cancer.